Mednext Biotech Limited, a active public limited company, was established on 17 August 2012 in Udaipur, Rajasthan, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232RJ2012PLC039813. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Mednext Biotech Private Limited. It upholds a compliant status. Employing 33 professional, Its leadership includes Anil Kumar Vyas (Director), Neelam Vyas (Director), Shriansh Vyas (Additional Director). Past directors included Vaishali Verma, Shriansh Vyas, Pankaj Vyas. It holds ₹16.59 Cr open charges and ₹10.01 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1St Floor, 30 Mahaveer Nagar New Bhupalpura, Udaipur, Rajasthan, 313001.
U24232RJ2012PLC039813
039813
17 August 2012
₹2.00 Cr
₹1.00 Cr
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Mednext Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Kumar Vyas | Director | 10 Oct 2017 | Current |
| Neelam Vyas | Director | 17 Aug 2012 | Current |
| Shriansh Vyas | Additional Director | 08 Feb 2025 | Current |
| Sunil Chittora | Director | 03 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Oct 2017 | Past |
| Pramod Abcsdd | Director | 03 Feb 2018 | Past |
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mednext Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.61% increase. The company also saw a substantial improvement in profitability, with a 116.78% increase in profit. The company's net worth Soared by an impressive increase of 77.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Mednext Biotech had a promoter holding of 99.21% and a public holding of 0.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹165,868,000.00
₹100,120,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 2022 | Others | ₹6.00 M | Open |
| 16 Mar 2022 | Others | ₹15.99 Cr | Open |
| 20 Jul 2020 | Others | ₹6.50 M | Satisfied |
| 01 Jun 2019 | Others | ₹5.61 Cr | Satisfied |
| 31 Mar 2018 | Others | ₹3.75 Cr | Satisfied |
Explore comprehensive loan charge details -
Mednext Biotech has a workforce of 33 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mednext Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mednext Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shriansh Vyas was appointed as a Additional Director was appointed as a Additional Director on 08 Feb 2025 & has been associated with this company since 9 months 25 days . was documented.
Progress on Mednext Biotech Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Mednext Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
Progress on A charge with Others of Rs. 15.99 Cr registered on 16 Mar 2022 with Charge ID 100549523 was modified on 13 Mar 2023. was documented.
The activity A charge registered on 20 Jul 2020 via Charge ID 100367609 with Others was fully satisfied on 13 Apr 2022. was completed.
Progress on A charge registered on 01 Jun 2019 via Charge ID 100265869 with Others was fully satisfied on 13 Apr 2022. was documented.
The CIN of Mednext Biotech Limited is U24232RJ2012PLC039813.
Mednext Biotech Limited is headquartered at 1St Floor, 30 Mahaveer Nagar New Bhupalpura, Udaipur, Rajasthan, 313001.
Mednext Biotech Limited was incorporated on 17 August 2012.
The current directors of Mednext Biotech Limited are
The primary industry of Mednext Biotech Limited is Manufacturing.
Mednext Biotech Limited is unlisted.
The authorized capital of Mednext Biotech Limited is ₹2.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Mednext Biotech Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX